Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 21- Open
- $128.07
- 52-wk high
- $212.75
- High
- $128.93
- 52-wk low
- $90.39
- Low
- $126.39
- Prev close
- $128.32
Smart money
Earnings
Earnings came in 24.6% above what analysts expected.
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $142.3M | $263.8M | $306.0M | $425.5M |
| Cost of what it sold | $29.4M | $44.2M | $49.5M | $67.2M |
| Gross profit | $113.0M | $219.6M | $256.5M | $358.3M |
| What it spent | ||||
| Research and development | $186.4M | $254.9M | $209.5M | $210.0M |
| Sales and admin | $186.4M | $212.5M | $247.3M | $247.5M |
| Other operating costs | $106.2M | — | — | -$97.7M |
| Total operating expenses | $479.0M | $469.3M | $456.7M | $359.8M |
| What was left | ||||
| Operating profit | -$366.0M | -$249.7M | -$200.3M | -$1.5M |
| Interest on debt | $20.4M | $20.6M | $20.1M | $20.3M |
| Profit before tax | -$368.7M | -$326.9M | -$162.1M | -$11.4M |
| Tax | $1.3M | $1.6M | $1.5M | $1.9M |
| Net profit | -$370.0M | -$328.5M | -$163.6M | -$13.2M |
| EBITDA | -$345.7M | -$302.1M | -$136.3M | $14.2M |
Technicals
Price structure
This stock is trending upward, and looks overbought after a fast run-up.
Trend
Constructive
60 / 100
RSI 14
20D volatility
52-week range
20D support
News
What the news says
Coverage is bullish
Tone of tracked coverage
Insmed CMO Martina Flammer sells $3.49m in company stock
NeutralAug 1713,000 Shares in Insmed, Inc. $INSM Purchased by S&CO Inc.
Leans bullishAug 16Insmed, Inc. $INSM Shares Bought by Empowered Funds LLC
Leans bullishAug 15